Guidance

Expiry date of Lagevrio (molnupiravir) antiviral medication extended

Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.

• From: Department of Health and Social Care
• Published: 5 December 2022
• Last updated: 26 January 2024
  Show all updates

  1. 26 January 2024

     Updated to reflect the MHRA’s approval of an additional 6 months' shelf life extension based on the latest stability data from the manufacturer.

  2. 21 August 2023

     The expiry dates of 3 lot (batch) numbers (W007683, W007684 and W007693) have been corrected on the table to show October 2023 (labelled) and April 2024 (extended).

  3. 20 December 2022

     Added lot (batch) numbers U035830, U035829 and U035827 to the table of specified batches of Lagevrio (molnupiravir) 200mg hard capsules that have had their shelf life extended.

  4. 5 December 2022

     First published.

This publication was withdrawn on 30 September 2025

The UK government no longer holds stocks of Lagevrio. It is now available from Alliance Healthcare on a commercial basis.

Documents

[Withdrawn] Lagevrio (molnupiravir) 200mg hard capsules expiry date extended

HTML

Details

The Department of Health and Social Care (DHSC) and pharmaceutical company MSD have extended the shelf life of specified batches of Lagevrio® (molnupiravir) 200mg hard capsules.

Some expiry dates have been extended to 36 months from 18 or 24 months following assessment by the Medicines and Healthcare products Regulatory Agency (MHRA).